Welcome to our dedicated page for Justera Health news (Ticker: SCRSF), a resource for investors and traders seeking the latest updates and insights on Justera Health stock.
Justera Health Ltd. (CSE: VTAL, OTC: SCRSF) is a Canadian health and wellness company whose news flow reflects activity across healthcare services, nutritional supplements, wellness experiences, cannabis products, and corporate finance. Established in 2020, the company regularly issues updates on its subsidiaries, capital structure decisions, and governance changes.
News about Justera often highlights developments in its personalized healthcare and wellness operations, including IV Vitamin Therapy services, the Naturevan Nutrition premium supplement brand, and the Juillet Wellness spa business, which offers registered massage therapy, acupuncture, and wellness-focused retail stores in Vancouver. These updates can provide context on how the company is positioning its health and wellness offerings.
A significant portion of Justera’s recent news has focused on its cannabis-related activities. The company announced the completion of its acquisition of Port North, a solventless cannabis extract brand operating from Port Elgin, Ontario, and has reported on Port North’s expansion into facilities operated by Lune Rise Farms. These releases describe Port North’s emphasis on pure, 100% solventless cannabis extracts and a product lineup that includes Hand Rolled Ice Water Hash, strain-specific full-spectrum gummies, and full-spectrum live rosin vapes.
Investors following SCRSF news will also see announcements on debt settlement transactions, RSU grants and vesting schedule changes under the company’s omnibus incentive plan, and governance items such as management changes and director resignations. In addition, Justera has reported a non-binding letter of intent to acquire Babbage Mining Co., a proof-of-stake mining operation, which the company states could enable it to accept certain crypto digital currencies as payment if the transaction is completed.
This news page aggregates these corporate, operational, and transaction-related updates in one place, allowing readers to review Justera Health’s disclosed activities and strategic moves over time.
Justera Health (CSE:VTAL)(OTC PINK:SCRSF) has successfully completed the acquisition of Port North Extracts Inc., a popular cannabis brand known for its solventless extraction techniques. The transaction, closed on October 16, 2024, involved exchanging 80,000,000 Justera common shares for 100% of Port North's outstanding shares at a deemed value of $0.02 per share. Additionally, Port North warrants were exchanged for Justera warrants with an exercise price of $0.05 per share.
The acquisition aims to diversify Justera's product offerings and expand its footprint in the cannabis sector. Joshua Herman, Port North's CEO, has joined Justera's Board of Directors. Justera plans to leverage Port North's expertise and market presence to drive expansion and profitability in the coming months.
Justera Health (CSE:VTAL)(OTC PINK:SCRSF) has announced a debt settlement agreement to settle an outstanding debt of approximately C$355,570. The company will issue 7,111,400 Units at a deemed price of C$0.05 per Unit to a non-arm's-length creditor. Each Unit consists of one Common share and one Share Purchase Warrant exercisable at $0.05 per share for an additional Common share, valid for 5 years.
The warrants include an acceleration clause for forced exercise if the company's shares trade at or above $0.10 for 5 consecutive trading days. The Board believes this settlement preserves cash for ongoing operations. The transaction is subject to a 4-month and 1-day hold period from issuance. As certain directors are insiders of the creditor, this is considered a "related party transaction" under MI 61-101, but the company intends to rely on exemptions from valuation and minority shareholder approval requirements.
Justera Health (CSE:VTAL)(OTC PINK:SCRSF) has signed a definitive agreement to acquire 100% of Port North Extracts Inc., a solventless cannabis brand. The transaction involves Justera issuing 80,000,000 common shares at a deemed value of $0.02 per share to Port North shareholders. Additionally, Port North warrants will be exchanged for Justera warrants exercisable at $0.05 per share. The acquisition aligns with Justera's strategy to diversify its portfolio and expand in the health and wellness sector, particularly in the cannabis market. Joshua Herman, Port North's CEO, is expected to join Justera's Board of Directors. The deal is subject to closing conditions, including regulatory approval and Port North having a minimum cash on hand of $150,000.
Justera Health has signed a non-binding Letter of Intent (LOI) to acquire all outstanding shares of Port North Extracts, a leading solventless cannabis brand. The acquisition involves issuing 110 million Justera shares at $0.02 each, valued at $2.2 million. Port North is raising $600K through a financing initiative. The completion of the transaction depends on meeting several conditions, including regulatory approvals and Port North having $600K in cash by closing. This acquisition aims to enhance Justera's product offerings and expand its market presence.
Justera Health (OTC Pink: SCRSF) announces a delay in filing its audited annual financial statements, which may lead to a failure-to-file cease trade order by the OSC. The Company is working to finalize the filings promptly to resume normal trading conditions.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.